-
MCC950 Sodium: Assay Design for NLRP3 Neuroinflammation
2026-08-26
MCC950 sodium, also known as CRID3 sodium salt, is a selective NLRP3 inflammasome inhibitor with utility beyond conventional macrophage assays. This guide translates evidence from a morphine-tolerance study into practical decisions for measuring inflammasome activity, astrocyte remodeling, and neuroinflammatory phenotypes.
-
WM-8014: Mechanism and KAT6A Inhibition
2026-08-26
WM-8014 is a potent, selective, reversible KAT6A inhibitor that competes with acetyl-CoA at the MYST-domain binding site. Its reported cellular effects include p16INK4A–p19ARF-associated senescence and cell cycle arrest in mouse embryonic fibroblasts, with concentration-dependent activity in a KRAS G12V zebrafish liver model.
-
Aztreonam Workflows for Gram-Negative Research
2026-08-25
Build reproducible Aztreonam assays that connect bacterial susceptibility, resistance-gene transmission, and host-response readouts. This workflow guide combines practical solution handling with orthogonal genomic, progenitor-cell, and hepatic enzyme experiments.
-
TRPV1 Modulation in Metastatic Breast Cancer
2026-08-25
The reference study shows that TRPV1 modulation produces disease-state- and metastasis-dependent immune effects in mice bearing 4T1 breast carcinoma. Its unexpected finding that AMG9810 behaved as an inverse agonist highlights why receptor activity, tumor context, and agonist exposure must be interpreted together before considering TRPV1-directed cancer strategies.
-
Gepotidacin: From Mechanism to Translational Strategy
2026-08-24
Gepotidacin, also known as GSK2140944, offers translational researchers a differentiated way to interrogate bacterial topoisomerase biology, DNA replication inhibition, and antibiotic resistance. This thought-leadership article connects biochemical potency, phenotypic assays, medicinal-chemistry precedent, exposure strategy, and practical material handling into a research roadmap.
-
6-FAM SE: Durable Amine-Reactive Labeling
2026-08-24
6-FAM SE, also called 6-Carboxyfluorescein N-hydroxysuccinimide ester, is an amine-reactive fluorescent labeling reagent for proteins, peptides, DNA derivatives, and nucleotides. Its NHS ester chemistry produces carboxamide-linked conjugates, while product specifications support DMSO stock preparation and storage at −20 °C.
-
CSBTA Pharmacokinetics in MASH Mice
2026-08-23
The 2025 reference study shows that MASH-like pathology can substantially alter the exposure, liver distribution, and hepatocyte accumulation of dehydrocavidine, palmatine, and berberine from Corydalis saxicola Bunting total alkaloids. By combining UHPLC-MS/MS pharmacokinetics with transporter, microsomal, and regulatory analyses, the work connects disease-associated pharmacokinetic variability with CYP450, Oatp1b2, P-gp, and PXR-related changes.
-
Norepinephrine bitartrate for Cardiomyopathy
2026-08-22
Learn how to deploy Norepinephrine bitartrate in receptor-signaling assays, cardiomyopathy models, and blood pressure studies without losing control of formulation or dose reporting. This workflow emphasizes fresh preparation, concentration-response design, and base-equivalent documentation for reproducible cross-laboratory results.
-
KPT330 and Cas9 Precision Through mRNA Export
2026-08-22
Cui and colleagues identified selective inhibitors of nuclear export, including KPT330, as indirect modulators that improve the specificity of Cas9 genome and base editing in human cells. The study links editing precision to the subcellular handling of Cas9 mRNA rather than direct inhibition of the Cas9 protein, offering a distinct strategy for temporal control of CRISPR activity.
-
Ampicillin Sodium: Assay Design and Workflow Logic
2026-08-21
Ampicillin sodium is a β-lactam antibiotic whose value depends on matching its cell-wall target to the correct experimental endpoint. This guide connects antibacterial activity assays with recombinant protein workflows, using a landmark annexin V purification study to clarify selection, potency, and reproducibility decisions.
-
SHC-1 Inhibition and CFTR Surface Trafficking
2026-08-20
This 2026 study shows that MAPK/SHC-1-dependent removal of CFTR from the plasma membrane is detectable across airway and intestinal epithelial models, but pharmacological responses are strongly cell-line dependent. Its key contribution is to separate pathway conservation from inhibitor selectivity, an important distinction for cystic fibrosis research and CFTR trafficking studies.
-
FAISL Stabilizes FAK to Drive TNBC Metastasis
2026-08-20
The reference study identifies FAISL as a long noncoding RNA that stabilizes focal adhesion kinase by blocking Calpain 2-mediated proteolysis, thereby strengthening malignant adhesion, survival, and metastatic behavior in triple-negative breast cancer. Its combination of RNA–protein interaction analysis, mechanistic cell studies, patient-data correlation, and nanoparticle siRNA delivery provides a framework for targeting FAK regulation beyond kinase inhibition.
-
Gepotidacin: First-in-Class Topoisomerase Antibiotic
2026-08-19
The 2023 reference review presents Gepotidacin, formerly GSK2140944, as a first-in-class oral triazaacenaphthylene antibiotic that blocks bacterial DNA replication through dual inhibition of DNA gyrase and topoisomerase IV. Its synthesis of mechanistic, microbiological, pharmacological, and Phase II evidence explains why the compound was being developed for uncomplicated urinary tract infections and urogenital gonorrhoea while also identifying important questions about resistance and clinical transferability.
-
EZ Cap™ Cas9 mRNA (m1Ψ) Workflow Guide
2026-08-19
Build transient CRISPR-Cas9 genome editing workflows around a Cap1-capped, m1Ψ-modified Cas9 transcript with practical controls for delivery, expression, and specificity. This guide connects product handling to nuclear-export findings while distinguishing validated evidence from assay starting points.
-
FITC-Concanavalin A (ConA) Conjugate Guide
2026-08-18
FITC-Concanavalin A (ConA) Conjugate is a fluorescent lectin reagent for visualizing α-D-glucose and α-D-mannose residues on cell surfaces and tissue samples. It is appropriate for carbohydrate-focused microscopy and flow cytometry workflows, but not for non-carbohydrate targets or use outside the stated storage and stability conditions.